Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Coronary artery disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Myocardial infarction wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac arrest wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
1432, either, cat. 46 FALLING INCIDENCE OF VENTRICULAR FIBRILLATION INCIDENCE AMONG OUT-OF-HOSPITAL CARDIAC ARRESTS J. Jensen1, C. Torp-Pedersen1, S.L. Nielsen2, G.H. Gislason1, F.K. Lippert3, F. Folke1 1 Copenhagen University Hospital, Gentofte, 2Mobile Emergency Care Unit of Copenhagen, 3Emergency Medicine and Emergency Medical Services, Head Office, The Capital Region of Denmark Introduction: Several studies have reported a decrease in the incidence of ventricular fibrillation (VF) among out-of-hospital cardiac arrests (OHCA) but none have been able to explain this ominous trend. Methods: We studied 4828 cases of OHCA in Copenhagen between 1994 and 2005. Data on concomitant treatment, comorbidity, and invasive treatment was retrieved for every patient and analyzed according to year of arrest. Results: Overall one-month OHCA survival was 6.1%, and no significant increase in survival was seen during the study period (P = 0.3270). The median age increased from 69 to 71 years with an ambulance response time of 5 minutes during the entire period. The number of cases presenting with VF as the initial rhythm decreased from 32% to 13% during the study period (P < 0.0001). Correspondingly, hospitalizations with a previous myocardial infarction fell from 19% to 10%, whereas diabetes increased from 8% to 11%, and obstructive pulmonary disease increased from 11% to 13%. There was an increased use of beta-blockers (from 6% to14%), ACE inhibitors (from 11% to 22%), cholesterol-lowering medications (from 1% to 11%), and antithrombotic medicine (from 13% to 30%). In contrast, anti-angina medication fell from 14% to 7%, and digoxin fell from 15% to 11%. Finally, the number of invasive procedures undergone by OHCA patients increased significantly. Conclusions: This study shows a clear relationship between the incidence of VF over time and changes in comorbidity, concomitant pharmacotherapy, and invasive cardiac procedures among OHCA patients.